Sign In

Anjali Gopalan, MD, MS

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612


anjali.gopalan@kp.org
Kaiser Permanente Researcher Profiles


Anjali Gopalan, MD, MS, is a research scientist in the Division of Research, Kaiser Permanente Northern California. Dr. Gopalan received her undergraduate degree in biochemistry and biology from Rice University. She completed medical school at Washington University in St. Louis. She then went on to complete an internal medicine residency at the University of Pennsylvania and was a member of the program's primary care track. Following residency she was a Robert Wood Johnson Clinical Scholar at the University of Pennsylvania and earned a Master's degree in Health Policy Research.. Her current research interests include the roles of information and communication for patients with chronic disease. Specifically, she is interested in researching alternative, more effective ways to present medical information to patients regarding chronic disease management, particularly diabetes.

Current Position(s):

  • Research Scientist I, Division of Research, Kaiser Permanente Northern California
  • Physician, Kaiser Permanente Oakland Medical Center

Section Affiliations:

Primary Research Interests:

  • Type 2 diabetes and pre-diabetes
  • Patient-provider communication
  • Information and risk presentation strategies
  • Behavioral economics

    Age- and race/ethnic-based disparities in diabetes outcomes among younger adults with newly diagnosed Type 2 Diabetes

    This study will conduct focus groups with KPNC members (age 45) with newly diagnosed Type 2 diabetes to learn about members’ experiences with this new diagnosis and to identify early facilitators of and barriers to effective diabetes management in this group.
    Investigator: Gopalan, Anjali
    Funder: Northern California Community Benefit Programs

    Metformin Initiation and Early Adherence among Kaiser Permanente Northern California Members with Newly Diagnosed Type 2 Diabetes

    Aim 1: Identify patient-level predictors of metformin treatment during the year following type 2 diabetes diagnosis. Examined factors will include: demographics, such as age, race/ethnicity, gender, and rural versus urban; clinical characteristics, such as A1c at diagnosis, diabetes-related comorbidities (hypertension, renal disease), number/type of other medications used, and gastrointestinal comorbidities (irritable bowel, H. pylori); and other care-related factors, such as medication copays, in-person visit copays, flu vaccination (proxy for openness to traditional treatment approaches), length of Kaiser Permanente Northern California membership, and primary care physician (PCP) contact/empanelment time. Aim 2: Identify provider-level predictors of early metformin treatment during the year following type 2 diabetes diagnosis. Examined factors will include: ordering provider type, such as PCP vs. other medical doctor versus other (e.g., population manager); PCP characteristics, such as PCP-member race concordance, PCP years in practice, and number of type 2 diabetes patients in panel; and primary Kaiser Permanente Northern California facility.
    Investigator: Gopalan, Anjali
    Funder: Northern California Community Benefit Programs

    The Initial Care of Younger Adults with Newly Diagnosed Type 2 Diabetes

    ​In a population of adults with newly diagnosed, early onset type 2 diabetes, this study will identify patient-, provider-, and system-level predictors of inadequate glycemic control within one year following diagnosis. A longitudinal, retrospective cohort analysis of electronic health record data will be conducted to examine associations between select factors and early glycemic control. This study will also explore barriers to and facilitators of type 2 diabetes care; patients and providers will be engaged in a qualitative process to identify barriers and facilitators affecting early diabetes care. Lastly, this project will examine associations between patient-reported factors and early glycemic control. To extend characterization of potentially modifiable care barriers in this population, validated instruments (selected based on existing literature and study findings) will be used to survey a cohort of patients and follow this cohort prospectively for one year to assess relationships between responses and glycemic control.
    Investigator: Gopalan, Anjali
    Funder: National Institute of Diabetes and Digestive and Kidney Diseases
    No results found matching criteria

    Disclosure of New Type 2 Diabetes Diagnoses to Younger Adults: a Qualitative Study

    Author(s): Gopalan A; Blatchins MA; Altschuler A; Mishra P; Fakhouri I; Grant RW

    J Gen Intern Med. 2021 Jan 26.

    PubMed abstract

    Testing patient-informed approaches for visually depicting the hemoglobin A1c value to patients with poorly controlled diabetes: a randomized, controlled trial

    Author(s): Gopalan A; Suttner L; Troxel AB; McDonough K; Schapira MM

    BMC Health Serv Res. 2020 Mar 06;20(1):178. Epub 2020-03-06.

    PubMed abstract

    Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes

    Author(s): Gopalan A; Mishra P; Alexeeff SE; Blatchins MA; Kim E; Man A; Karter AJ; Grant RW

    Diabetes Care. 2020 Mar 04.

    PubMed abstract

    Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes

    Author(s): Weiner JZ; Gopalan A; Mishra P; Lipska KJ; Huang ES; Laiteerapong N; Karter AJ; Grant RW

    JAMA Intern Med. 2019 Sep 23.

    PubMed abstract

    Use of financial incentives and text message feedback to increase healthy food purchases in a grocery store cash back program: a randomized controlled trial

    Author(s): Gopalan A; Shaw PA; Lim R; Paramanund J; Patel D; Zhu J; Volpp KG; Buttenheim AM

    BMC Public Health. 2019 May 31;19(1):674. Epub 2019-05-31.

    PubMed abstract

    Exploring how patients understand and assess their diabetes control

    Author(s): Gopalan A; Kellom K; McDonough K; Schapira MM

    BMC Endocr Disord. 2018 Nov 06;18(1):79. Epub 2018-11-06.

    PubMed abstract

    Prevalence and predictors of delayed clinical diagnosis of Type 2 diabetes: a longitudinal cohort study

    Author(s): Gopalan A; Mishra P; Alexeeff SE; Blatchins MA; Kim E; Man AH; Grant RW

    Diabet Med. 2018 Sep 03.

    PubMed abstract

    Research to Change Health Delivery Systems: On the Outside Looking in?

    Author(s): Gopalan A; Grant RW

    J Gen Intern Med. 2018 Jul 20.

    PubMed abstract

    Identifying Geographic Disparities in Diabetes Prevalence Among Adults and Children Using Emergency Claims Data

    Author(s): Lee DC; Gallagher MP; Gopalan A; Osorio M; Vinson AJ; Wall SP; Ravenell JE; Sevick MA; Elbel B

    J Endocr Soc. 2018 May 01;2(5):460-470. Epub 2018-04-17.

    PubMed abstract

    A systematic review of care management interventions targeting multimorbidity and high care utilization

    Author(s): Baker JM; Grant RW; Gopalan A

    BMC Health Serv Res. 2018 01 30;18(1):65. Epub 2018-01-30.

    PubMed abstract

    Population Health Management for Diabetes: Health Care System-Level Approaches for Improving Quality and Addressing Disparities

    Author(s): Schmittdiel JA; Gopalan A; Lin MW; Banerjee S; Chau CV; Adams AS

    Curr Diab Rep. 2017 May;17(5):31.

    PubMed abstract

    Randomised controlled trial of alternative messages to increase enrolment in a healthy food programme among individuals with diabetes

    Author(s): Gopalan A; Paramanund J; Shaw PA; Patel D; Friedman J; Brophy C; Buttenheim AM; Troxel AB; Asch DA; Volpp KG

    BMJ Open. 2016 Nov 30;6(11):e012009. Epub 2016-11-30.

    PubMed abstract

    Health-Specific Information and Communication Technology Use and Its Relationship to Obesity in High-Poverty, Urban Communities: Analysis of a Population-Based Biosocial Survey

    Author(s): Gopalan A; Makelarski JA; Garibay LB; Escamilla V; Merchant RM; Wolfe MB; Holbrook R; Lindau ST

    J Med Internet Res. 2016;18(6):e182. Epub 2016-06-28.

    PubMed abstract